The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ABCELLERA BIOLOGICS INC | COM | 00288U106 | 196,736 | 9,817,190 | SH | DFND | 1 | 9,817,190 | 0 | 0 | |
| ARQIT QUANTUM INC | ORIDNARY SHARES | G0567U101 | 10,035 | 500,000 | SH | DFND | 1 | 500,000 | 0 | 0 | |
| AURORA ACQUISITION CORP | CLASS A ORD SHS | G0698L103 | 26,811 | 2,700,000 | SH | DFND | 1 | 2,700,000 | 0 | 0 | |
| AURORA ACQUISITION CORP | *W EXP 03/02/202 | G0698L129 | 1,067 | 675,000 | SH | Call | DFND | 1 | 675,000 | 0 | 0 |
| BLUE WHALE ACQUISITION CORP | CLASS A ORD SHS | G1330M103 | 9,775 | 998,000 | SH | DFND | 1 | 998,000 | 0 | 0 | |
| BLUE WHALE ACQUISITION CORP | *W EXP 07/30/202 | G1330M129 | 2 | 249,500 | SH | Call | DFND | 1 | 249,500 | 0 | 0 |
| CM LIFE SCIENCES III INC | CLASS A COM | 125841106 | 19,112 | 1,926,600 | SH | DFND | 1 | 1,926,600 | 0 | 0 | |
| CM LIFE SCIENCES III INC | *W EXP 04/30/202 | 125841114 | 1,712 | 800,000 | SH | Call | DFND | 1 | 800,000 | 0 | 0 |
| COMPUTE HEALTH ACQUISITIN CO | COM CL A | 204833107 | 39,080 | 4,000,000 | SH | DFND | 1 | 4,000,000 | 0 | 0 | |
| COMPUTE HEALTH ACQUISITIN CO | *W EXP 01/25/202 | 204833115 | 965 | 1,000,000 | SH | Call | DFND | 1 | 1,000,000 | 0 | 0 |
| DOMA HOLDINGS INC | COMMON STOCK | 25703A104 | 19,768 | 2,671,401 | SH | DFND | 1 | 2,671,401 | 0 | 0 | |
| ELLIOTT OPPORTUNITY II CORP | SHS CL A | G30092103 | 48,213 | 4,950,000 | SH | DFND | 1 | 4,950,000 | 0 | 0 | |
| ELLIOTT OPPORTUNITY II CORP | *W EXP 03/02/202 | G30092111 | 1,361 | 1,237,500 | SH | Call | DFND | 1 | 1,237,500 | 0 | 0 |
| FTAC ATHENA ACQUISITION CORP | *W EXP 03/01/202 | G37283119 | 650 | 500,000 | SH | Call | DFND | 1 | 500,000 | 0 | 0 |
| FTAC HERA ACQUISITION CORP | CLASS A ORD SHS | G3728Y103 | 48,700 | 5,000,000 | SH | DFND | 1 | 5,000,000 | 0 | 0 | |
| FTAC HERA ACQUISITION CORP | *W EXP 02/28/202 | G3728Y111 | 1,288 | 1,250,000 | SH | Call | DFND | 1 | 1,250,000 | 0 | 0 |
| KHOSLA VENTURES ACQUT CO III | COM CL A | 482506102 | 39,200 | 4,000,000 | SH | DFND | 1 | 4,000,000 | 0 | 0 | |
| LYELL IMMUNOPHARMA INC | COM | 55083R104 | 51,800 | 3,500,000 | SH | DFND | 1 | 3,500,000 | 0 | 0 | |
| MONTES ARCHIMEDES ACQUISITIO | COM CL A | 612657106 | 23,375 | 2,500,000 | SH | DFND | 1 | 2,500,000 | 0 | 0 | |
| PACIFIC BIOSCIENCES CALIF IN | COM | 69404D108 | 208,389 | 8,156,107 | SH | DFND | 1 | 8,156,107 | 0 | 0 | |
| PIONEER MERGER CORP | *W EXP 01/07/202 | G7S24C111 | 1,008 | 916,666 | SH | Call | DFND | 1 | 916,666 | 0 | 0 |
| REVOLUTION HEALTHCAR AQ CORP | CLASS A COM | 76155Y108 | 29,130 | 3,000,000 | SH | DFND | 1 | 3,000,000 | 0 | 0 | |
| REVOLUTION HEALTHCAR AQ CORP | *W EXP 12/31/202 | 76155Y116 | 557 | 600,000 | SH | Call | DFND | 1 | 600,000 | 0 | 0 |
| SANA BIOTECHNOLOGY INC | COM | 799566104 | 49,747 | 2,209,004 | SH | DFND | 1 | 2,209,004 | 0 | 0 | |
| SCVX CORP | *W EXP 01/24/202 | G79448117 | 400 | 500,000 | SH | Call | DFND | 1 | 500,000 | 0 | 0 |
| SOMALOGIC INC | CLASS A COM | 83444K105 | 27,258 | 2,200,000 | SH | DFND | 1 | 2,200,000 | 0 | 0 | |
| SEMA4 HOLDINGS CORP | COM CL A | 81663L101 | 68,473 | 9,021,524 | SH | DFND | 1 | 9,021,524 | 0 | 0 | |
| SVF INVESTMENT CORP | UNIT 12/20/2025 | G8601L110 | 21,868 | 2,200,000 | SH | DFND | 1 | 2,200,000 | 0 | 0 | |
| SVF INVESTMENT CORP 2 | CL A SHS | G8601M100 | 9,820 | 1,000,000 | SH | DFND | 1 | 1,000,000 | 0 | 0 | |
| SVF INVESTMENT CORP 3 | CL A SHS | G8601N108 | 19,660 | 2,000,000 | SH | DFND | 1 | 2,000,000 | 0 | 0 | |